Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we will assume that you are happy to receive all cookies and you will not see this message again. Click 'Find out more' for information on how to change your cookie settings.

The World Parkinson Coalition has brought in eight new Science Ambassadors to increase outreach to researchers ahead of their next major Congress.

OPDC career development fellow Dr Dayne Beccano-Kelly has been selected by The World Parkinson Coalition (WPC) to be one of eight Science Ambassadors in the two years leading up to the 6th World Parkinson Congress in June 2022. The WPC Ambassadors will be promoting a premiere Parkinson’s learning experience for scientists, working to bring the Parkinson's community together to advance both the clinical and research goals of discovering new treatments.

Dr Beccano-Kelly has been a member of the Wade-Martins Group since 2015, where he has been utilising human iPSCs donated by people with Parkinson's (PwP) to create neurons for Parkinsonian models. Studying these models has enabled him to identify some of the earliest changes in Parkinson's in an effort to tackle the symptoms before they develop into the late stages.

On receiving his appointment, Dr Beccanno-Kelly said: "The WPC represents a powerful point of contact between medics, academic and PwPs. Bringing these individuals together allows the perspectives and ideas of each to be easily communicated to one another. Attending my first WPC in 2019, I was struck by how much these mix of viewpoints seemed to be influencing people's future plans; it was exciting to watch a novel way of pushing forwards towards better treatments. The WPC not only represents a triennial meeting, but also provides virtual panel led discussion groups and connections with the community (via online events such as choir groups) in the interim years. It is a tremendous meeting and one I will be strongly advocating healthcare professionals, PwPs and other scientists to attend!"

Read the appointment announcement on the WPC website.

Meet all eight WPC 2022 Science Ambassadors on the 6th World Parkinson Congress website.

Similar stories

Just over half of British Indians would take COVID vaccine

EDI News Outreach Postdoctoral Publication Research Riley Group News

University of Oxford researchers from the Department of Physiology, Anatomy and Genetics (DPAG) and the Department of Psychiatry, in collaboration with The 1928 Institute, have published a major new study on the impact of COVID-19 on the UK’s largest BME population.

Earliest origins of the forming heart identified

Cardiac Theme Postdoctoral Publication Research

The earliest known progenitor of the outermost layer of the heart has been characterised for the first time and linked to the development of other critical cell types in the developing heart in a new paper from the Srinivas group led by BHF Immediate Fellow Dr Richard Tyser.

Lukas Krone to represent Oxford at the Global Young Scientists Summit

Awards and Honours EDI News Head of Department's News Students Vyazovskiy Group News

Congratulations are in order for Dr Lukas Krone who is one of just five University of Oxford researchers selected to attend the Global Young Scientists Summit 2021.

Covid-19 lung damage identified in study

Postdoctoral Research

In a new study into the longer-term damage amongst patients recovering from COVID-19, DPAG Research Fellow Dr James Grist of the Tyler Lab has been running a novel scanning technique that shows a dramatic decrease in the ability of the lungs to diffuse gas in to the blood stream after COVID infection. This work may shed light on the problem of breathlessness after COVID infection and help guide us in understanding therapeutic selection and efficacy.

New MRI technique could detect early signs of heart failure in cancer patients following chemotherapy

Cardiac Theme Postdoctoral Publication Research

New research led by Oxford BHF CRE Intermediate Transition Fellow Dr Kerstin Timm shows that a recently developed imaging technique pioneered by the Tyler Group can detect early metabolic changes in the heart caused by a commonly used chemotherapy drug, which is known to increase risk of heart failure in cancer survivors.

Two major BHF awards to Neil Herring pave the way to new treatments for heart attack patients

Awards and Honours Cardiac Theme

Associate Professor Neil Herring has been awarded a Senior Clinical Research Fellowship and a Project grant from the British Heart Foundation to further critical research into the mechanisms behind heart attacks and heart failure and potential drugs to combat them. Given the 50% reduction in research investment this year from the BHF due to the impact of COVID-19, Prof Herring is to be congratulated on these awards.